No. Innovaccer is private and has not filed to go public; 2026 is the earliest year discussed. There is no S-1 on file.
What is Innovaccer's valuation in 2026?
Innovaccer is valued at $1.3B as of 2025-Q1, set by its Series F-1 ($153.04M, Jan 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Innovaccer filed an S-1?
No public S-1 is on file for Innovaccer.
Who are Innovaccer's investors?
Innovaccer's investors include B Capital Group, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente, M12 and 13 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Innovaccer provides a Healthcare Intelligence Cloud that transforms fragmented healthcare data into actionable insights, enhancing patient care and operational efficiency. The platform integrates data across clinical, operational, and financial systems to support value-based care initiatives, population health management, risk adjustment, and AI-powered clinical workflows for healthcare providers, payers, and life sciences organizations.
Company Profile
CEO
Abhinav Shashank
Founded
2014
HQ
San Francisco, California
Employees
1,200+
Total Raised
$675M
Est. Revenue
$250M (2025-Q1)
Growth
50% year-over-year revenue growth for the past five years; positive cash flow in Q4 2024; serves six of the top 10 health systems
Last Round
Series F-1 — $153.04M (Jan 2025)
IPO Status
Private
Fundraising Status
Series F-1 · $153.04M · 1y 7mo ago
PrivateTotal raised $675M
Secondary Market
Implied price / share
$2.44
Last round price / share
$7.39
vs last round
-67.0%
Open interest
5
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F-1
$153.04M
Jan 2025
—
—
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
3
via careers page
Product-build share
33%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 33% builders vs 67% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Specialty Pharmacyjoin the talent community\\ \\ join the talent communityFinancial Performance
Counted from Innovaccer's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
B Capital Group · Banner Health · Danaher Ventures · Generation Investment Management · Kaiser Permanente · M12 · Tiger Global · Mubadala · OMERS · Lightspeed India · WestBridge Capital · Whale Rock Capital Management · Schonfeld · Dragoneer Investment Group · Steadview · Avidity Partners · Pravega Ventures · Peak XV Partners · BAM Corner Point
Products
Health Cloud
Population Health Management
Patient Engagement
Provider Networks
Sara AI
Value-Based Care AI
Risk Adjustment
Quality Management
Provider Copilot
Care Management Copilot
Access Center
Data Activation Platform
Agents of Care
GHAAP
Competitors
Epic · Health Catalyst · Komodo Health · Datavant · Optum · Salesforce · Cerner · Athena · Aidoc · Heidi Health · Ambience Healthcare · Arcadia
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q1. Refreshed quarterly.